0001062993-22-016669.txt : 20220722
0001062993-22-016669.hdr.sgml : 20220722
20220722161432
ACCESSION NUMBER: 0001062993-22-016669
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220712
FILED AS OF DATE: 20220722
DATE AS OF CHANGE: 20220722
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Flynn Steven
CENTRAL INDEX KEY: 0001938766
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-04448
FILM NUMBER: 221100097
MAIL ADDRESS:
STREET 1: ONE BAXTER PARKWAY
CITY: DEERFIELD
STATE: IL
ZIP: 60015
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BAXTER INTERNATIONAL INC
CENTRAL INDEX KEY: 0000010456
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 360781620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BAXTER PKWY
STREET 2: DF2-1W
CITY: DEERFIELD
STATE: IL
ZIP: 60015
BUSINESS PHONE: 8479482000
MAIL ADDRESS:
STREET 1: ONE BAXTER PARKWAY
STREET 2: DF2-1W
CITY: DEERFIELD
STATE: IL
ZIP: 60015
FORMER COMPANY:
FORMER CONFORMED NAME: BAXTER TRAVENOL LABORATORIES INC
DATE OF NAME CHANGE: 19880522
FORMER COMPANY:
FORMER CONFORMED NAME: BAXTER LABORATORIES INC
DATE OF NAME CHANGE: 19760608
3
1
form3.xml
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
X0206
3
2022-07-12
0
0000010456
BAXTER INTERNATIONAL INC
BAX
0001938766
Flynn Steven
ONE BAXTER PARKWAY
ONE BAXTER PARKWAY
DEERFIELD
IL
60015
0
1
0
0
SVP, President, APAC
Common Stock, $1 par value
11709
D
Stock Option (Right to Buy)
37.38
2025-03-03
Common Stock, $1 par value
4887
D
Stock Option (Right to Buy)
50.77
2027-03-02
Common Stock, $1 par value
11230
D
Stock Option (Right to Buy)
66.31
2028-03-01
Common Stock, $1 par value
8402
D
Stock Option (Right to Buy)
74.73
2029-02-28
Common Stock, $1 par value
10288
D
Stock Option (Right to Buy)
75.75
2030-03-20
Common Stock, $1 par value
12715
D
Stock Option (Right to Buy)
77.15
2031-03-03
Common Stock, $1 par value
15207
D
Stock Option (Right to Buy)
85.23
2032-03-02
Common Stock, $1 par value
6064
D
The options became exercisable in three equal annual installments beginning on March 3, 2016, the first anniversary of the grant date.
The options became exercisable in three equal annual installments beginning on March 2, 2018, the first anniversary of the grant date.
The options became exercisable in three equal annual installments beginning on March 1, 2019, the first anniversary of the grant date.
The options became exercisable in three equal annual installments beginning on February 28, 2020, the first anniversary of the grant date.
The options become exercisable in three equal annual installments beginning on March 22, 2021, the first anniversary of the grant date. The first two installments became exercisable on March 22, 2021 and March 21, 2022 respectively. The third installment will become exercisable on March 20, 2023.
The options become exercisable in three equal annual installments beginning on March 3, 2022, the first anniversary of the grant date. The first installment became exercisable on March 3, 2022. The second and third installment will become exercisable on March 3, 2023 and March 4, 2024 respectively.
The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date.
/s/ Ellen K. Bradford, as attorney in-fact for Steven Flynn
2022-07-22
EX-24
2
exhibit24.txt
POWER OF ATTORNEY
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and
appoints each of David S. Rosenbloom, Ellen K. Bradford and Matthew Rice
signing singly, the undersigned's true and lawful attorney in fact to:
(1) execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer and/or director of Baxter
International Inc., or any of its direct or indirect subsidiaries (Baxter)
Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities
Exchange Act of 1934 and the rules thereunder and Form 144 under
Rule 144 under the Securities Act of 1933;
(2) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and execute
any such Form 3, 4, 5, or 144 and complete and execute any amendment or
amendments thereto, and timely file any such form with the United States
Securities and Exchange Commission and any stock exchange or similar
authority; and
(3) take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such attorney in fact, may
be of benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney in fact on behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain such terms and
conditions as such attorney in fact may approve in such attorney in
fact's discretion.
The undersigned hereby grants to each such attorney in fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of
the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do if personally present,
with full power of substitution or revocation, hereby ratifying and
confirming all that such attorney in fact, or such attorney in fact's
substitute or substitutes, shall lawfully do or cause or have caused
to be done by virtue of this power of attorney and the rights and
powers herein granted. The undersigned acknowledges that the foregoing
attorneys in fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is Baxter assuming, any of the
undersigned's responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934 and Rule 144 of the Securities Act
of 1933.
This Power of Attorney shall super cede any power of attorney
previously granted by the undersigned with respect to the subject
matter herein and shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, 5 and 144 with
respect to the undersigned's holdings of, and transactions in,
securities issued by Baxter, unless earlier revoked by the
undersigned in a signed document delivered to Baxter.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of July 11, 2022.
/s/ Steven Flynn